Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.65 |
| ▸ | CA12 | O43570 | 2/20 | 0.65 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.65 |
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CA2 | P00918 | 2/20 | 0.65 |
| ▸ | CA3 | P07451 | 2/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.65 |
| ▸ | CA4 | P22748 | 2/20 | 0.65 |
| ▸ | CA6 | P23280 | 2/20 | 0.65 |
| ▸ | DPP4 | P27487 | 2/20 | 0.65 |
| ▸ | CA5A | P35218 | 2/20 | 0.65 |
| ▸ | CA7 | P43166 | 2/20 | 0.65 |
| ▸ | CA9 | Q16790 | 2/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.65 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.65 |
| ▸ | ESR1 | P03372 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | TYR | P14679 | 1/20 | 0.65 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL126171 | 1.00 | CYP1A2 (0.72) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| SCHEMBL269140 | 1.00 | CYP1A2 (0.72) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| Hydrochloric Acid SCHEMBL5929339 | 0.98 | CYP1A2 (0.69) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| Hydrochloric Acid SCHEMBL27093050 | 0.98 | CYP1A2 (0.69) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| SCHEMBL11452510 | 0.98 | CYP1A2 (0.69) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| Methyl Alcohol SCHEMBL27319502 | 0.96 | CYP1A2 (0.67) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| SCHEMBL3859316 | 0.94 | HDAC2 (0.68) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| SCHEMBL3859319 | 0.94 | HDAC2 (0.68) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| SCHEMBL4985018 | 0.89 | PLA2G4A (0.60) | CYP1A2HCAR2CA12AKR1B10CA1 | |
| SCHEMBL4985013 | 0.89 | PLA2G4A (0.60) | CYP1A2HCAR2CA12AKR1B10CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11915925-B2 | Semiconductor device manufacturing method | DAICEL CORPORATION (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11915925-B2 | Semiconductor device manufacturing method | DAICEL CORPORATION (JP) | 2024-02-27 | — | — | US | disclosed |
| WO-2023182238-A1 | TEMPORARY ADHESIVE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR WAFER LAMINATE USING THE TEMPORARY ADHESIVE | 株式会社ダイセル | 2023-09-28 | — | — | WO | disclosed |
| US-11710731-B2 | Semiconductor device manufacturing method | DAICEL CORPORATION (JP) | 2023-07-25 | — | — | US | disclosed |
| US-11710731-B2 | Semiconductor device manufacturing method | DAICEL CORPORATION (JP) | 2023-07-25 | — | — | US | disclosed |
| US-20210391165-A1 | SEMICONDUCTOR DEVICE MANUFACTURING METHOD | DAICEL CORPORATION (JP) | 2021-12-16 | — | — | US | disclosed |
| US-20210384183-A1 | SEMICONDUCTOR DEVICE MANUFACTURING METHOD | DAICEL CORPORATION (JP) | 2021-12-09 | — | — | US | disclosed |
| US-20210358884-A1 | SEMICONDUCTOR DEVICE MANUFACTURING METHOD | DAICEL CORPORATION (JP) | 2021-11-18 | — | — | US | disclosed |
| US-10947425-B2 | Adhesive | DAICEL CORPORATION (JP) | 2021-03-16 | — | — | US | disclosed |
| US-10711162-B2 | Adhesive agent | DAICEL CORPORATION (JP) | 2020-07-14 | — | — | US | disclosed |
| US-20190119534-A1 | ADHESIVE | DAICEL CORPORATION (JP) | 2019-04-25 | — | — | US | disclosed |
| US-20160264822-A1 | ADHESIVE AGENT | DAICEL CORPORATION (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160264822-A1 | ADHESIVE AGENT | DAICEL CORPORATION (JP) | 2016-09-15 | — | — | US | disclosed |
| EP-1791969-A4 | A METHOD OF TREATING CANCER | MERCK & CO INC (US) | 2008-07-02 | — | — | EP | disclosed |
| EP-1791969-A2 | A METHOD OF TREATING CANCER | Merck & Co., Inc. (US) | 2007-06-06 | — | — | EP | disclosed |
| EP-1718628-A1 | CINNAMIC AMIDES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Active Biotech AB (SE) | 2006-11-08 | — | — | EP | disclosed |
| WO-2006031607-A2 | A METHOD OF TREATING CANCER | MERCK & CO., INC. (US) | 2006-03-23 | — | — | WO | disclosed |
| US-20050192289-A1 | Novel cinnamic amides | ACTIVE BIOTECH AB (SE) | 2005-09-01 | — | — | US | disclosed |
| WO-2005080362-A1 | CINNAMIC AMIDES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ACTIVE BIOTECH AB (SE) | 2005-09-01 | — | — | WO | disclosed |
| US-4966694-A | CELLULOSE TRI-BETA-NAPHTHOATE; OPTICAL RESOLUTIONS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1990-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192289-A1 | Novel cinnamic amides | NFATC1, H1-5, HDAC1 | CYP1A2 444/4885HCAR2 74/4885CA12 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.